Mirati Therapeutics Inc
NASDAQ:MRTX
Cash Flow Statement
Cash Flow Statement
Mirati Therapeutics Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Income |
(48)
|
(53)
|
(62)
|
(65)
|
(45)
|
(44)
|
(42)
|
(46)
|
(57)
|
(65)
|
(75)
|
(81)
|
(82)
|
(83)
|
(79)
|
(75)
|
(72)
|
(70)
|
(67)
|
(77)
|
(88)
|
(98)
|
(125)
|
(142)
|
(169)
|
(213)
|
(259)
|
(296)
|
(329)
|
(358)
|
(407)
|
(491)
|
(483)
|
(582)
|
(634)
|
(645)
|
(738)
|
(741)
|
(737)
|
(738)
|
(726)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
|
Stock-Based Compensation |
3
|
3
|
4
|
5
|
6
|
7
|
8
|
10
|
10
|
10
|
11
|
10
|
10
|
11
|
9
|
9
|
8
|
7
|
9
|
10
|
13
|
16
|
23
|
32
|
43
|
56
|
66
|
74
|
81
|
86
|
89
|
96
|
101
|
114
|
132
|
142
|
158
|
186
|
190
|
191
|
193
|
|
Other Non-Cash Items |
19
|
23
|
33
|
36
|
14
|
12
|
8
|
8
|
11
|
11
|
11
|
11
|
10
|
11
|
9
|
9
|
8
|
7
|
8
|
10
|
12
|
15
|
21
|
29
|
40
|
52
|
63
|
72
|
68
|
70
|
78
|
90
|
105
|
126
|
145
|
153
|
160
|
177
|
170
|
163
|
170
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
2
|
0
|
(2)
|
2
|
(2)
|
(1)
|
0
|
1
|
3
|
3
|
5
|
5
|
3
|
4
|
0
|
(4)
|
(3)
|
(1)
|
4
|
9
|
13
|
14
|
7
|
(1)
|
3
|
13
|
23
|
31
|
24
|
16
|
5
|
43
|
49
|
66
|
49
|
0
|
(4)
|
(10)
|
(37)
|
(18)
|
(43)
|
|
Cash from Operating Activities |
(27)
N/A
|
(29)
-9%
|
(31)
-5%
|
(27)
+11%
|
(32)
-16%
|
(33)
-3%
|
(34)
-3%
|
(37)
-10%
|
(43)
-17%
|
(51)
-17%
|
(58)
-14%
|
(66)
-13%
|
(68)
-4%
|
(68)
0%
|
(69)
-2%
|
(70)
-1%
|
(67)
+5%
|
(65)
+4%
|
(54)
+16%
|
(58)
-7%
|
(63)
-9%
|
(70)
-11%
|
(97)
-38%
|
(114)
-18%
|
(127)
-11%
|
(148)
-17%
|
(172)
-17%
|
(193)
-12%
|
(237)
-23%
|
(272)
-15%
|
(323)
-19%
|
(357)
-11%
|
(327)
+8%
|
(389)
-19%
|
(439)
-13%
|
(489)
-11%
|
(580)
-19%
|
(571)
+2%
|
(600)
-5%
|
(588)
+2%
|
(594)
-1%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(8)
|
(9)
|
(10)
|
(10)
|
(7)
|
(7)
|
(5)
|
(4)
|
(3)
|
(2)
|
|
Other Items |
4
|
(29)
|
(27)
|
(29)
|
(26)
|
25
|
(9)
|
(7)
|
4
|
(50)
|
(20)
|
(21)
|
(25)
|
38
|
(2)
|
(1)
|
(1)
|
(9)
|
(52)
|
(86)
|
(71)
|
(146)
|
(96)
|
(76)
|
(233)
|
(175)
|
(261)
|
(277)
|
(83)
|
(135)
|
(468)
|
(406)
|
(469)
|
(579)
|
(74)
|
(10)
|
2
|
231
|
375
|
287
|
210
|
|
Cash from Investing Activities |
4
N/A
|
(29)
N/A
|
(27)
+9%
|
(29)
-8%
|
(26)
+10%
|
24
N/A
|
(10)
N/A
|
(8)
+21%
|
4
N/A
|
(51)
N/A
|
(20)
+61%
|
(21)
-7%
|
(25)
-18%
|
38
N/A
|
(3)
N/A
|
(1)
+52%
|
(1)
+17%
|
(9)
-724%
|
(53)
-507%
|
(86)
-64%
|
(71)
+17%
|
(146)
-105%
|
(96)
+34%
|
(76)
+21%
|
(233)
-206%
|
(176)
+24%
|
(263)
-49%
|
(280)
-6%
|
(87)
+69%
|
(140)
-60%
|
(473)
-238%
|
(414)
+13%
|
(477)
-15%
|
(589)
-23%
|
(84)
+86%
|
(18)
+79%
|
(4)
+75%
|
226
N/A
|
371
+64%
|
284
-24%
|
208
-27%
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
25
|
55
|
55
|
55
|
55
|
1
|
49
|
49
|
144
|
144
|
98
|
98
|
2
|
2
|
67
|
67
|
69
|
159
|
98
|
230
|
230
|
141
|
246
|
335
|
334
|
337
|
566
|
353
|
364
|
1 251
|
921
|
920
|
916
|
505
|
498
|
491
|
640
|
167
|
166
|
169
|
346
|
|
Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
25
N/A
|
55
+120%
|
55
+0%
|
55
+0%
|
55
+0%
|
1
-98%
|
49
+5 433%
|
49
+0%
|
144
+192%
|
144
+0%
|
98
-32%
|
98
0%
|
3
-97%
|
3
-10%
|
67
+2 434%
|
67
0%
|
69
+3%
|
159
+130%
|
98
-38%
|
230
+135%
|
230
+0%
|
141
-39%
|
247
+75%
|
336
+36%
|
335
0%
|
338
+1%
|
566
+67%
|
353
-38%
|
364
+3%
|
1 251
+243%
|
921
-26%
|
920
0%
|
916
0%
|
505
-45%
|
498
-1%
|
491
-1%
|
640
+30%
|
167
-74%
|
166
0%
|
169
+1%
|
346
+105%
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
Net Change in Cash |
2
N/A
|
(4)
N/A
|
(3)
+36%
|
(1)
+54%
|
(3)
-120%
|
(8)
-184%
|
6
N/A
|
5
-19%
|
105
+2 060%
|
43
-59%
|
20
-53%
|
11
-45%
|
(90)
N/A
|
(27)
+70%
|
(5)
+82%
|
(5)
+5%
|
1
N/A
|
85
+8 606%
|
(9)
N/A
|
86
N/A
|
96
+12%
|
(75)
N/A
|
54
N/A
|
146
+170%
|
(24)
N/A
|
14
N/A
|
130
+820%
|
(120)
N/A
|
40
N/A
|
839
+2 008%
|
125
-85%
|
149
+19%
|
111
-25%
|
(472)
N/A
|
(25)
+95%
|
(15)
+39%
|
56
N/A
|
(178)
N/A
|
(63)
+65%
|
(136)
-116%
|
(40)
+70%
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Free Cash Flow |
(27)
N/A
|
(30)
-9%
|
(31)
-5%
|
(28)
+11%
|
(32)
-16%
|
(33)
-3%
|
(34)
-3%
|
(37)
-10%
|
(44)
-17%
|
(51)
-17%
|
(58)
-14%
|
(66)
-13%
|
(68)
-4%
|
(68)
0%
|
(69)
-2%
|
(71)
-2%
|
(67)
+5%
|
(65)
+4%
|
(54)
+16%
|
(58)
-7%
|
(63)
-9%
|
(70)
-11%
|
(97)
-38%
|
(114)
-18%
|
(127)
-11%
|
(149)
-18%
|
(174)
-17%
|
(196)
-13%
|
(241)
-23%
|
(276)
-14%
|
(328)
-19%
|
(365)
-11%
|
(336)
+8%
|
(399)
-19%
|
(449)
-13%
|
(496)
-11%
|
(586)
-18%
|
(575)
+2%
|
(604)
-5%
|
(591)
+2%
|
(596)
-1%
|